---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-004768"
form_type: "8-K"
ticker: null
cik: "0001621227"
company_name: "Adaptimmune Therapeutics PLC"
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:29:38.560745+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adaptimmune extends CFO Gavin Wood's departure to August 31, 2025

## Summary
- Original termination date of May 31, 2025 changed to August 31, 2025 by reason of redundancy.
- Severance includes 12 months base salary, discretionary pro-rata bonus for 2025, and healthcare benefits for 12 months.
- Share options continue vesting until August 31, 2025; vested options exercisable for 12 months thereafter.
- All other provisions of the original letter agreement and service agreement obligations survive unchanged.

## SEC filing metadata
- accession: 0001558370-25-004768
- form_type: 8-K
- cik: 0001621227
- company_name: Adaptimmune Therapeutics PLC
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621227/000155837025004768/0001558370-25-004768-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621227/000155837025004768/adap-20250414x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-004768
- JSON: https://secwatch.observer/filing/0001558370-25-004768.json
- Plain text: https://secwatch.observer/filing/0001558370-25-004768.txt

## Key facts
- Executive change
  Gavin Wood departed as Chief Financial Officer at Adaptimmune Therapeutics PLC.
  - Action: departure
  - Role: Chief Financial Officer
  source text: Mr. Wood’s employment with Adaptimmune Limited will end on August 31, 2025 (the “Revised Termination Date”) by reason of redundancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621227/000155837025004768/0001558370-25-004768-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.